North America HIV Drugs Market Analysis, Recent Trends and Regional Growth Forecast by 2026
According to the latest report by IMARC Group, titled, “North America HIV Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the North America HIV drugs market size reached US$ 10.2 Billion in 2020. Looking forward, the market is expected to exhibit negative growth during (2021-2026).
HIV is the human immunodeficiency virus, a type of retrovirus that damages the immune system by destroying white blood cells that fight infection. HIV infection is treated by antiretroviral therapy (ART) with HIV drugs. ART patients have been prescribed with a combination of HIV drugs, and that regimen must be followed daily. Antiretroviral treatment does not cure HIV but allows people with this infection to lead healthier and longer lives. HIV drugs make the immune system strong enough to resist certain diseases and prevent the multiplication of HIV.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/north-america-hiv-drugs-market/requestsample
The wide presence of advanced healthcare infrastructures in North America is primarily driving the market growth. Additionally, the introduction of favorable government support policies and investment funds for the development of potent and safer HIV drugs is also augmenting the product demand. Furthermore, the extensive adoption of antiretroviral medications has led to an improvement in survival rates and the quality of life of HIV patients, thereby catalyzing the market for HIV drugs in North America.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report has segmented the market on the basis of Drug Class, Distribution Channel and Country.
Market by Drug Class
- Nucleoside Reverse Transcriptase Inhibitors
- Multi-Class Combination Products
- Protease Inhibitors
- HIV Integrase Strand Transfer Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Entry Inhibitors — CCR5 Co-Receptor Antagonist
Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Competitive Structure
- Key Player Profiles
For more information about this report visit: https://www.imarcgroup.com/north-america-hiv-drugs-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Follow us on twitter: @imarcglobal